Age-stratified analysis of serotype-specific baseline immunity against group B streptococcus

References

• Ohlsson A, Shah VS. Intrapartum antibiotics for known maternal Group B streptococcal colonization. Cochrane Database Syst Rev. 2014;6:Cd007467. doi:10.1002/14651858.CD007467.pb4. PMID:24915629.
   PubMed Web of Science ®Google Scholar
• Madhi SA, Dangor Z, Heath PT, Schrag S, Izu A, Sobanjo-Ter Meulen A, Dull PM. Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants. Vaccine. 2013;31(Suppl 4):D52–57. doi:10.1016/j.vaccine.2013.02.029. PMID:23973347.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Active bacterial core surveillance report, emerging infections program network, Group B streptococcus. 2016. [accessed 2018 Aug 31]. https://www.cdc.gov/abcs/reports-findings/survreports/gbs16.html
   Google Scholar
• Song JY, Lim JH, Lim S, Yong Z, Seo HS. Progress toward a group B streptococcal vaccine. Hum Vaccin Immunother. 2018;14(11):2669–81. doi:10.1080/21645515.2018.1493326. PMID:29995578.
   PubMed Web of Science ®Google Scholar
• Edwards MS, Gonik B. Preventing the broad spectrum of perinatal morbidity and mortality through group B streptococcal vaccination. Vaccine. 2013;31(Suppl 4):D66–71. doi:10.1016/j.vaccine.2012.11.046. PMID:23200934.
   PubMedGoogle Scholar
• Kobayashi M, Schrag SJ, Alderson MR, Madhi SA, Baker CJ, Sobanjo-Ter Meulen A, Kaslow DC, Smith PG, Moorthy VS, Vekemans J. WHO consultation on group B Streptococcus vaccine development: report from a meeting held on 27–28 April 2016. Vaccine. 2016. doi:10.1016/j.vaccine.2016.12.029. PMID:28017431.
   PubMedGoogle Scholar
• Balmer P, Borrow R, Miller E. Impact of meningococcal C conjugate vaccine in the UK. J Med Microbiol. 2002;51(9):717–22. doi:10.1099/0022-1317-51-9-717. PMID:12358061.
   PubMed Web of Science ®Google Scholar
• Choi MJ, Noh JY, Cheong HJ, Kim WJ, Lin SM, Zhi Y, Lim JH, Lim S, Seo HS, Song JY. Development of a multiplexed opsonophagocytic killing assay (MOPA) for group B Streptococcus. Hum Vaccin Immunother. 2018;14(1):67–73. doi:10.1080/21645515.2017.1377379. PMID:28933634.
   PubMed Web of Science ®Google Scholar
• Brigtsen AK, Dedi L, Melby KK, Holberg-Petersen M, Radtke A, Lyng RV, Andresen LL, Jacobsen AF, Fugelseth D, Whitelaw A. Comparison of PCR and serotyping of Group B Streptococcus in pregnant women: the Oslo GBS-study. J Microbiol Methods. 2015;108:31–35. doi:10.1016/j.mimet.2014.11.001. PMID:25447890.
   PubMed Web of Science ®Google Scholar
• Dangor Z, Kwatra G, Izu A, Lala SG, Madhi SA. Review on the association of Group B Streptococcus capsular antibody and protection against invasive disease in infants. Expert Rev Vaccines. 2015;14(1):135–49. doi:10.1586/14760584.2014.953939. PMID:25242617.
   PubMed Web of Science ®Google Scholar
• Edwards MS, Nizet V, Baker CJ. Group B streptococcal infections. In: Remington JS, Klien JO, Baker CJ, Wilson CB, editors. Infectious diseases of the fetus and newborn infant. 6th ed. Philadelphia: WB Saunders Co; 2006. p. 1091–141..
   Google Scholar
• Edwards MS, Rench MA, Palazzi DL, Baker CJ. Group B streptococcal colonization and serotype-specific immunity in healthy elderly persons. Clin Infect Dis. 2005;40(3):352–57. doi:10.1086/426820. PMID:15668856.
   PubMed Web of Science ®Google Scholar
• Baker CJ, Carey VJ, Rench MA, Edwards MS, Hillier SL, Kasper DL, Platt R. Maternal antibody at delivery protects neonates from early onset group B streptococcal disease. J Infect Dis. 2014;209(5):781–88. doi:10.1093/infdis/jit549. PMID:24133184.
   PubMed Web of Science ®Google Scholar
• Lin FY, Philips JB 3rd, Azimi PH, Weisman LE, Clark P, Rhoads GG, Regan J, Concepcion NF, Frasch CE, Troendle J, et al. Level of maternal antibody required to protect neonates against early-onset disease caused by group B Streptococcus type Ia: a multicenter, seroepidemiology study. J Infect Dis. 2001;184(8):1022–28. doi:10.1086/323350. PMID:11574917.
   PubMed Web of Science ®Google Scholar
• Lin FY, Weisman LE, Azimi PH, Philips JB 3rd, Clark P, Regan J, Rhoads GG, Frasch CE, Gray BM, Troendle J, et al. Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen. J Infect Dis. 2004;190(5):928–34. doi:10.1086/422756. PMID:15295698.
   PubMed Web of Science ®Google Scholar
• Baker CJ, Paoletti LC, Rench MA, Guttormsen HK, Edwards MS, Kasper DL. Immune response of healthy women to 2 different group B streptococcal type V capsular polysaccharide-protein conjugate vaccines. J Infect Dis. 2004;189(6):1103–12. doi:10.1086/382193. PMID:14999615.
   PubMed Web of Science ®Google Scholar
• Baker CJ, Rench MA, McInnes P. Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine. Vaccine. 2003;21(24):3468–72. doi:10.1016/S0264-410X(03)00353-0. PMID:12850362.
   PubMed Web of Science ®Google Scholar
• Edwards MS, Lane HJ, Hillier SL, Rench MA, Baker CJ. Persistence of functional antibodies to group B streptococcal capsular polysaccharides following immunization with glycoconjugate vaccines. Vaccine. 2012;30(28):4123–26. doi:10.1016/j.vaccine.2012.04.048. PMID:22537994.
   PubMed Web of Science ®Google Scholar
• Baker CJ, Paoletti LC, Wessels MR, Guttormsen HK, Rench MA, Hickman ME, Kasper DL. Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib. J Infect Dis. 1999;179(1):142–50. doi:10.1086/314574. PMID:9841833
   PubMed Web of Science ®Google Scholar
• Palazzi DL, Rench MA, Edwards MS, Baker CJ. Use of type V group B streptococcal conjugate vaccine in adults 65–85 years old. J Infect Dis. 2004;190(3):558–64. doi:10.1086/422010. PMID:15243932.
   PubMed Web of Science ®Google Scholar
• Baker CJ, Rench MA, Paoletti LC, Edwards MS. Dose-response to type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine in healthy adults. Vaccine. 2007;25(1):55–63. doi:10.1016/j.vaccine.2006.07.018. PMID:16919857.
   PubMed Web of Science ®Google Scholar
• Kwatra G, Adrian PV, Shiri T, Buchmann EJ, Cutland CL, Madhi SA. Natural acquired humoral immunity against serotype-specific group B Streptococcus rectovaginal colonization acquisition in pregnant women. Clin Microbiol Infect. 2015;21(6):568.e513–521. doi:10.1016/j.cmi.2015.01.030. PMID:25680313.
   PubMedGoogle Scholar
• Le Doare K, Faal A, Jaiteh M, Sarfo F, Taylor S, Warburton F, Humphries H, Birt J, Jarju S, Darboe S, et al. Association between functional antibody against Group B Streptococcus and maternal and infant colonization in a Gambian cohort. Vaccine. 2017;35(22):2970–78. doi:10.1016/j.vaccine.2017.04.013. PMID:28449969.
   PubMed Web of Science ®Google Scholar
• Kim HW, Lee JH, Cho HK, Lee H, Seo HS, Lee S, Kim KH. Opsonophagocytic antibodies to serotype Ia, Ib, and III Group B streptococcus among Korean infants and in intravenous immunoglobulin products. J Korean Med Sci. 2017;32(5):737–43. doi:10.3346/jkms.2017.32.5.737. PMID:28378545.
   PubMed Web of Science ®Google Scholar
• Song JY, Moseley MA, Burton RL, Nahm MH. Pneumococcal vaccine and opsonic pneumococcal antibody. J Infect Chemother. 2013;19(3):412–25. doi:10.1007/s10156-013-0601-1. PMID:23657429.
   PubMed Web of Science ®Google Scholar
• Davies HD, Adair C, McGeer A, Ma D, Robertson S, Mucenski M, Kowalsky L, Tyrell G, Baker CJ. Antibodies to capsular polysaccharides of group B Streptococcus in pregnant Canadian women: relationship to colonization status and infection in the neonate. J Infect Dis. 2001;184(3):285–91. doi:10.1086/322029. PMID:11443553.
   PubMed Web of Science ®Google Scholar
• Calvert A, Jones CE. Placental transfer of antibody and its relationship to vaccination in pregnancy. Curr Opin Infect Dis. 2017;30(3):268–73. doi:10.1097/qco.0000000000000372. PMID:28362650.
   PubMed Web of Science ®Google Scholar
• Chiarot E, Spagnuolo A, Maccari S, Naimo E, Acquaviva A, Cecchi R, Galletti B, Fabbrini M, Mori E, Ruggiero P, et al. Protective effect of Group B Streptococcus type-III polysaccharide conjugates against maternal colonization, ascending infection and neonatal transmission in rodent models. Sci Rep. 2018;8(1):2593. doi:10.1038/s41598-018-20609-5. PMID:29416049.
   PubMedGoogle Scholar
• Lee K, Shin JW, Chong Y, Mikamo H. Trends in serotypes and antimicrobial susceptibility of group B streptococci isolated in Korea. J Infect Chemother. 2000;6(2):93–97. doi:10.1007/PL00012158.
   PubMedGoogle Scholar
• Kang HM, Lee HJ, Lee H, Jo DS, Lee HS, Kim TS, Shin JH, Yun KW, Lee B, Choi EH. Genotype characterization of group B streptococcus isolated from infants with invasive diseases in South Korea. Pediatr Infect Dis J. 2017;36(10):e242–e247. doi:10.1097/INF.0000000000001531.
   PubMed Web of Science ®Google Scholar
• Kim DH, Min BJ, Jung EJ, Byun JM, Jeong DH, Lee KB, Sung MS, Kim KT, Kim YN. Prevalence of group B streptococcus colonization in pregnant women in a tertiary care center in Korea. Obstet Gynecol Sci. 2018;61(5):575–83. doi:10.5468/ogs.2018.61.5.575.
   PubMedGoogle Scholar
• Lee HT, Kim SY, Park PW, Ahn JY, Kim KH, Seo JY, Jeong JH, Kwoun WJ, Seo YH. Detection and genomic analysis of genital group B streptococcus in pregnant Korean women. J Obstet Gynecol Res. 2019;45(1):69–77. doi:10.1111/jog.13810.
   Google Scholar
• Hong J-S, Choi CW, Park K-U, Kim SN, Lee HJ, Lee HR, Choi EH, Park KH, Suh CS, Kim BI. Genital group B Streptococcus carrier rate and serotype distribution in Korean pregnant women: implications for group B streptococcal disease in Korean neonates. J Perinat Med. 2010;38(4):373–77. doi:10.1515/jpm.2010.050.
   PubMed Web of Science ®Google Scholar
• Seo YS, Srinivasan U, Oh K-Y, Shin J-H, Chae JD, Kim MY, Yang JH, Yoon H-R, Miller B, DeBusscher J, et al. Changing molecular epidemiology of group B streptococcus in Korea. J Korean Med Sci. 2010;25(6):817–23. doi:10.3346/jkms.2010.25.6.817.
   PubMed Web of Science ®Google Scholar
• Yoon IA, Jo DS, Cho EY, Choi EH, Lee HJ, Lee HJ. Clinical significance of serotype V among infants with invasive group B streptococcal infections in South Korea. Int J Infect Dis. 2015;38:136–40. doi:10.1016/j.ijid.2015.05.017.
   PubMed Web of Science ®Google Scholar
• Patras KA, Nizet V. Group B streptococcal maternal colonization and neonatal disease: molecular mechanisms and preventative approaches. Front Pediatr. 2018;6(27):1–17. doi:10.3389/fped.2018.00027. PMID:29520354.
   PubMedGoogle Scholar
• Bodaszewska-Lubas M, Brzychczy-Wloch M, Adamski P, Gosiewski T, Strus M, Heczko PB. Adherence of group B streptococci to human rectal and vaginal epithelial cell lines in relation to capsular polysaccharides as well as alpha-like protein genes - pilot study. Pol J Microbiol. 2013;62(1):85–90. PMID:23829083.
   PubMed Web of Science ®Google Scholar
• Patras KA, Rosler B, Thoman ML, Doran KS. Characterization of host immunity during persistent vaginal colonization by group B streptococcus. Mucosal Immunol. 2015;8(6):1339–48. doi:10.1038/mi.2015.23. PMID:25850655.
   PubMed Web of Science ®Google Scholar
• Rinaudo CD, Rosini R, Galeotti CL, Berti F, Necchi F, Reguzzi V, Ghezzo C, Telford JL, Grandi G, Maione D. Specific involvement of pilus type 2a in biofilm formation in group B streptococcus. PLoS One. 2010;5(2):e9216. doi:10.1371/journal.pone.0009216. PMID:20169161.
   PubMed Web of Science ®Google Scholar
• Vekemans J, Crofts J, Baker CJ, Goldblatt D, Heath PT, Madhi SA, Le Doare K, Andrews N, Pollard AJ, Saha SK, et al. The role of immune correlates of protection on the pathway to licensure, policy decision and use of group B Streptococcus vaccines for maternal immunization: considerations from World Health Organization consultations. Vaccine. 2019;37(24):3190–98. doi:10.1016/j.vaccine.2019.04.039.
   PubMed Web of Science ®Google Scholar
• Le Doare K, Kampmann B, Vekemans J, Heath PT, Goldblatt D, Nahm MH, Baker C, Edwards MS, Kwatra G, Andrews N, et al. Serocorrelates of protection against infant group B streptococcus disease. Lancet Infect Dis. 2019;19(5):e162–e172. doi:10.1016/S1473-3099(18)30659-5.
   PubMed Web of Science ®Google Scholar